Want to see RPRX full AI Analyst Report?
Royalty Pharma (RPRX) Revenue
1,352 Followers
Royalty Pharma Revenue
Royalty Pharma had a revenue of 690.00M in the quarter ending Sep 30, 2026, with 2.35%. This bring the company's revenue in the last twelve months to 2.62B, Increased 3.18%. In the fiscal year ending Dec 31, 2025, Royalty Pharma had annual revenue of 2.38B with 5.06% growth.
- Revenue (ttm)
- 2.62B
- Revenue Growth
- 11.34%
- P/S Ratio
- 16.37
- Revenue/Employee
- $23,781,930
- Employees
- 100
- Market Cap
- $38.94B
Revenue Chart
Royalty Pharma Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.38B | 114.62M | 5.06% |
| Dec 31, 2024 | 2.26B | -90.98M | -3.86% |
| Dec 31, 2023 | 2.35B | 117.34M | 5.24% |
| Dec 31, 2022 | 2.24B | -52.25M | -2.28% |
| Dec 31, 2021 | 2.29B | 167.11M | 7.87% |
| Dec 31, 2020 | 2.12B | 308.10M | 16.98% |
| Dec 31, 2019 | 1.81B | 19.36M | 1.08% |
| Dec 31, 2018 | 1.79B | 196.96M | 12.33% |
| Dec 31, 2017 | 1.60B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.